1.
Prebet T, Fenaux P, Vey N. Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system. Haematologica 2016; 101(10):e427-e428; https://doi.org/10.3324/haematol.2016.150714.